2011 Programme

Evidence 2011 - Tuesday 25th October
08:00	Registration
09:00	Opening presentation: Welcome to Evidence 2011 Fiona Godlee Editor in Chief, BMJ
09:10	K1 Keynote: Evidence & policy for improved outcomes and reduced costs Carl Heneghan Director, Centre for Evidence-Based Medicine, University of Oxford
09:50	A1 1. Evidence based commissioning Gary Belfield 2. Effective Medical Testing Patrick M.M. Bossuyt Professor of Clinical Epidemiology, University of Amsterdam A1 Session: Effective Medical Testing Patrick M.M. Bossuyt Professor of Clinical Epidemiology, University of Amsterdam 25th Oct 2011 - 09:50 The unraveling of the human genome and the expansion of genomics, proteomics and metabolomics have fuelled the development of novel biomarkers and other forms of medical testing. Additional information can improve health care, bringing us closer to stratified and personalized medicine How do we find out of these medical tests offer value for money? What single idea will make the biggest impact on healthcare today? In themselves, biomarkers and medical tests do not improve health; studies to document their value should reflect their effects on patients outcome. Aimed at which audience People who make recommendations and decisions about medical tests. Experience level Experienced. Chaired by Fiona Godlee Editor in Chief, BMJ Chaired by Fiona Godlee Editor in Chief, BMJ	A2 1. Pathways for effective healthcare Dr Steven Laitner MBBS, MSc, DCH, MRCP(UK), MRCGP, MFPHM 2. Evidence, ethics and quality Tammy Clifford Chief Scientist at the Canadian Agency for Drugs and Technologies in Health A2 Session: Evidence, ethics and quality Tammy Clifford Chief Scientist at the Canadian Agency for Drugs and Technologies in Health 25th Oct 2011 - 09:50 Health technology assessment (HTA) is used to inform many – but not all - health care decisions; the extent to which it is explicitly incorporated into decision making processes varies extensively over time, across jurisdictions, and according to local context. While “return on investment” may be difficult to quantify, systematic use of HTA can contribute to the “value for money” proposition by supporting the decisions that provide high-quality, equitable care in a sustainable system. What single idea will make the biggest impact on healthcare today? Systematic use of the “best evidence” to support informed decisions will translate to better patient outcomes, more equitable healthcare and a sustainable health care system Learning outcomes – after this session, participants will be able to: To understand how the discipline of HTA can marry clinical, economic, financial and ethical considerations. Through case studies, to appreciate the context(s) when HTA has worked, when it hasn’t – and why. To identify possible solutions to current challenges on the global HTA landscape. Aimed at which audience Those involved in health care decision making – whether at the policy or practice level; Those who carry out research that can inform health care decisions. Experience level Experienced	A3 1. The CRASH-2 trial: The treatment works but how do we ensure that patients benefit? Professor Ian Roberts Director, Clinical Trials Unit, London School of Hygiene & Tropical Medicine A3 Session: The CRASH-2 trial: The treatment works but how do we ensure that patients benefit? Professor Ian Roberts Director, Clinical Trials Unit, London School of Hygiene & Tropical Medicine 25th Oct 2011 - 09:50 The CRASH-2 investigators were privileged to have been granted over two million pounds of public funds to search for a safe and effective treatment for trauma patients. Thanks to the dedication and trust of a network of clinicians from around the world, the search was successful. Tranexamic acid substantially reduces mortality with no increase in adverse effects. World-wide, this inexpensive drug could save over 100,000 lives per year. The task now is dissemination and implemented and both present challenges. What single idea will make the biggest impact on healthcare today Global access to all cost-effective health-care. Learning outcomes – after this session, participants will be able to Action learning: Share responsibility for ensuring that the public funds invested in the CRASH-2 trial are used for maximal patient benefit Aimed at which audience and what level Everyone 2. Research provides the evidence for low cost intervention Richard Feinmann International Hospital Kampala supported by Voluntary Service Overseas & Target TB A3 Session: Research provides the evidence for low cost intervention Richard Feinmann International Hospital Kampala supported by Voluntary Service Overseas & Target TB 25th Oct 2011 - 09:50 TB is a major killer in sub-Saharan Africa. Culturing the organism to confirm diagnosis i,to provide diagnosis and drug sensitivity, is expensive and rarely done. We describe a research project showing the effectiveness of a low cost,low tech intervention in HIV sufferers, which we are now using routinely in Uganda. What single idea will make the biggest impact on healthcare today? A low cost investigation can provide better management of TB across sub-Saharan Africa. Learning outcomes – after this session, participants will be able to: Simple research can provide evidence which can have a major impact in some of the poorest countries TB has again become a major killer, as a result of the HIV epidemic, and this curable disease needs proper resourcing To persuade governments to adopt new health care practices requires well researched evidence Aimed at which audience and what level Everyone
10:50	Refreshments
11:20	K2 Introduction: Introduction to the global evidence base for anti-doping in sport Michael Stow Head of Science and Medicine, UK Anti-Doping Agency
11:30	K3 Keynote: Doping in sport: the evidence for performance enhancement in Olympic and Paralympic athletes Yannis P Pitsiladis MMEDSci., PhD, FACSM
12:10	K4 Keynote: Evidence for affordable healthcare Professor Sir Bruce Keogh Medical Director of the National Health Service in England
12:50	Lunch & Poster viewing
13:50	B1 Complex social interventions: challenges to the EBM model? Paul Montgomery Reader in Psycho-Social Intervention, University of Oxford Professor Trisha Greenhalgh Healthcare Innovation and Policy Unit Lead, Barts and The London School of Medicine B1 Session: Complex social interventions: challenges to the EBM model? Paul Montgomery Reader in Psycho-Social Intervention, University of Oxford Professor Trisha Greenhalgh Healthcare Innovation and Policy Unit Lead, Barts and The London School of Medicine 25th Oct 2011 - 13:50 This session will consider complex social interventions and ask whether the EBM paradigm can expand sufficiently to embrace them. We will look at the MRC Framework for Complex Interventions as well as a paper which described difficulties applying this in practice in the context of a large health promotion study. What single idea will make the biggest impact on healthcare today? Researchers who develop and test complex interventions are divided on how useful the EBM approach is. Learning outcomes Consider the challenges involved in evaluating complex interventions Present both ‘for’ and ‘against’ arguments in relation to the use of the MRC Framework for Developing and Evaluating Complex Interventions in complex social interventions Aimed at which audience Any Experience level Medium Chaired by Carl Heneghan Director, Centre for Evidence-Based Medicine, University of Oxford Chaired by Carl Heneghan Director, Centre for Evidence-Based Medicine, University of Oxford	B2 1. Chewing on the evidence Derek Richards B2 Session: Chewing on the evidence Derek Richards 25th Oct 2011 - 13:50 The Centre for Evidence-based Dentistry was established in 1994. The presentation will provide an overview of evidence-based developments in dentistry, highlighting key developments and future challenges. For example, evidence-based prevention programmes, and service re-design, guideline development, evidence-based research networks, translational research and improving research quality. What single idea will make the biggest impact on healthcare today? Access to best available knowledge for all can drive change and improve care Learning outcomes – after this session, participants will be able to To assess the impact of evidence-based dentistry To identify challenges to further implementation of evidence-based approaches in dentistry Aimed at which audience All healthcare professionals Experience Level Beginner 2. Evidence-based Veterinary Medicine for All Creatures Great and Small Rachel Dean Associate Professor in Feline Medicine, Centre for Evidence-based Veterinary Medicine, School of Veterinary Medicine and Science, University of Nottingham B2 Session: Evidence-based Veterinary Medicine for All Creatures Great and Small Rachel Dean Associate Professor in Feline Medicine, Centre for Evidence-based Veterinary Medicine, School of Veterinary Medicine and Science, University of Nottingham 25th Oct 2011 - 13:50 The extent to which veterinarians practice evidence-based medicine remains unknown. The Centre for Evidence-based Veterinary Medicine (CEVM) formed 2 years ago and the CEVM’s early work will be presented. The tools of EBM and how/if they can be applied to veterinary practice will be discussed including: methods of systematic review, practice-based research, education and ‘putting research into practice ‘. The difficulty measuring clinical outcomes, from Gerbils to Giraffes, will also be highlighted. What single idea will make the biggest impact on healthcare today? When making decisions in veterinary practice we need to stop and think; How much evidence do we have and is it any good? Learning outcomes – after this session, participants will be able to: To identify the challenges of introducing EBM principles into veterinary practice To identify the limitations of veterinary evidence To identify the factors that may contribute to clinical decision making in veterinary practice Aimed at which audience Everyone Experience level Beginner 3. Evidence in The Coroner's Court: how clinical and circumstantial evidence is analysed at an Inquest Dr Andrew Scott Reid HM Coroner Inner North London	B3 INNOVATION ROOM A selection of rapid fire presentation of cutting edge innovations in evidence delivery. 13:50 Health Foundation Research for Health Service Improvement: the role of the Health Foundation Dr Kion Ahadi, Darshan Patel, Jonathan Bamber 14:30 DELL Cross Enterprise Document Sharing and Healthcare Information Exchanges and their influence on clinical workflow Dr. Mohammed Hussein B3 Session: INNOVATION ROOM 25th Oct 2011 - 13:50 A selection of rapid fire presentation of cutting edge innovations in evidence delivery. 13:50 Health Foundation Research for Health Service Improvement: the role of the Health Foundation Dr Kion Ahadi, Research and Development Manager Darshan Patel, Research and Development Manager Jonathan Bamber, Research and Development Manager In this session we outline the Health Foundation’s approach to Research and development. Evidence is at the heart of everything we do and we are committed to developing knowledge that shapes and supports our improvement programmes around the UK. This mix of research evidence and real world experience helps us influence future healthcare policy and practice. We highlight with recent examples from our projects how research evidence can help inform service design. Learning outcomes – after this session, participants will be able to To develop knowledge of Improvement Science To identify learning from a range of recent healthcare research projects To understand the use of evidence in service design Experience Level Experienced 14:30 DELL Cross Enterprise Document Sharing and Healthcare Information Exchanges and their influence on clinical workflow Dr. Mohammed Hussein, Clinical Radiologist and Senior Programme Management Consultant Chaired by Matthew Thompson Deputy Director, Centre for Evidence-Based Medicine, University of Oxford Chaired by Matthew Thompson Deputy Director, Centre for Evidence-Based Medicine, University of Oxford
15:10	Refreshments & poster viewing
15:40	C1 1. Developing the best bets for emergency medicine Professor Kevin Mackway Jones MA, FRCP, FRCSEd, FCEM Executive Medical Director, NW Ambulance Service 2. The 'dirty' side of evidence based dermatology Hywel Williams Director of the Centre of Evidence-Based Dermatology, University of Nottingham C1 Session: The 'dirty' side of evidence based dermatology Hywel Williams Director of the Centre of Evidence-Based Dermatology, University of Nottingham 25th Oct 2011 - 15:40 Part of me lives in a world of trying to produce clean evidence in the form of systematic reviews and randomized controlled trials to inform decision making in dermatology. But part of me works in a busy NHS clinic where I have to face the realities of translating imperfect evidence into practice. In this talk, I shall explore some of the ideas that help me translate evidence based on groups of people to individual patients. What single idea will make the biggest impact on healthcare today? Stop fiddling with the NHS – it is a complex adaptive system containing good people who need to be allowed to develop best practice Learning outcomes – after this session, participants will be able to: At the end of the session, the participant will be able to list at least 3 factors that might help them to apply external evidence more appropriately to shared decision making with patients. Aimed at which audience Mainly healthcare professionals Experience level Beginner	C2 Strengthening evidence for rational investment for addressing noncommunicable diseases Shanthi Mendis World Health Organization C2 Session: Strengthening evidence for rational investment for addressing noncommunicable diseases Shanthi Mendis World Health Organization 25th Oct 2011 - 15:40 Progress and advances in medicine related to noncommunicable diseases are moving rapidly ahead, leaving behind the vulnerable and disadvantaged people in developed and developing countries. Underprivileged populations in developing countries particularly, are dying in large numbers for want of access to basic preventive and curative care. Explicit consideration of social, economic and political factors that have a bearing on health inequities should be an integral part of national policy development and implementation for prevention and control of noncommunicable diseases. What single idea will make the biggest impact on healthcare today? Appropriate investment in preventive and curative health care to ensure equity Learning outcomes – after this session, participants will be able to: To identify multiple barriers to NCD policy development and implementation in LMIC. To recognize that policy development and implementation are context driven due to political and cultural specificities and differences in administrative and governance systems. To identify strategies which have helped in development and successful implementation of policies for NCD prevention and control. Aimed at which audience Senior Managers Experience level Experienced	C3 RESEARCH SHOWCASE A selection of rapid-fire presentations highlighting the best of evidence based research in the scientific community. C3 Session: RESEARCH SHOWCASE 25th Oct 2011 - 15:40 A selection of rapid-fire presentations highlighting the best of evidence based research in the scientific community. Chaired by Fiona Godlee Editor in Chief, BMJ Chaired by Fiona Godlee Editor in Chief, BMJ
16:40	K5 Keynote: Complementary and alternative medicine: the evidence debate Edzard Ernst Professor of Complementary Medicine, NHS K5 Keynote: Complementary and alternative medicine: the evidence debate Edzard Ernst Professor of Complementary Medicine, NHS 25th Oct 2011 - 16:40 A brief summary as it pertains to complementary/alternative medicine. The talk will cover subjects such as therapeutic effectiveness and safety of various popular therapies for defined conditions. Emphasis will be on critical assessment of the existing evidence. What single idea will make the biggest impact on healthcare today? Complementary/alternative medicine can and must be evaluated just like any other healthcare technologies. Learning outcomes – after this session, participants will be able to: Establish how the value of complementary/alternative medicine should be determined, define the effectiveness of complementary/alternative medicine, define the risk associated with complementary/alternative medicine. Aimed at which audience All healthcare professionals Experience level All levels.
17:30	Poster reception event - drinks and canapés

Evidence 2011 - Wednesday 26th October
08:00	Registration	Breakfast Session Not quite NICE, but thrifty and nifty: The Scottish Approach to developing advice and guidance Karen Ritchie, Healthcare Improvement Scotland Roberta James, Scottish Intercollegiate Guidelines Network (SIGN) Ann Lee, Scottish Medicines Consortium Karen Macpherson, Scottish Health Technologies Group Breakfast Session Session: Not quite NICE, but thrifty and nifty: The Scottish Approach to developing advice and guidance 26th Oct 2011 - 08:00 Karen Ritchie, Healthcare Improvement Scotland Roberta James, Scottish Intercollegiate Guidelines Network (SIGN) Ann Lee, Scottish Medicines Consortium Karen Macpherson, Scottish Health Technologies Group We will present the approach taken to developing clinical guidelines and HTA advice for NHSScotland on new medicines and other technologies. We will discuss how the groups involved in this work share knowledge and collaborate to avoid conflicting advice and are working together to address some of the key challenges in healthcare provision in the 21st century. What single idea from your lecture, will make the biggest impact on healthcare today? That high quality advice and guidance on clinical management and health technologies can be developed in way that is cost effective and responsive to practitioners’ needs. Learning outcomes – after this session, participants will be able to Describe how NHSScotland develops and delivers evidence based advice and guidance Understand some of the challenges of developing such guidance for the health service in Scotland Identify differences in approach of the NHS in England and Scotland to similar problems Experience Level Beginner, though some understanding of health technology assessment and guideline development would be useful.	Breakfast Session Session information coming soon Speakers TBA Breakfast Session Session: Session information coming soon 26th Oct 2011 - 08:00 Speakers TBA
09:00	K6 Introduction: Fighting your inner quack Ben Goldacre Award-winning writer, broadcaster, and medical doctor, writer of the weekly Guardian Bad Science column, and author of the book 'Bad Science'
09:10	K7 Keynote: Communicating risk and uncertainty David Spiegelhalter Winton Professor of the Public Understanding of Risk, University of Cambridge K7 Keynote: Communicating risk and uncertainty David Spiegelhalter Winton Professor of the Public Understanding of Risk, University of Cambridge 26th Oct 2011 - 09:10 Shared decision-making requires a shared understanding of the possible benefits and harms of different options. I will look at the ways in which the chances of different outcomes are communicated to patients, emphasising the use of multiple representations that can adapt to individual needs, tastes and abilities. Acknowledging uncertainties about the chances themselves may only be appropriate for some patients. Transparent communication to individuals may not have the consequences desired by those concerned with the health of the population. Learning outcomes – after this session, participants will be able to: Identify options for communicating risk Accept range of needs and understanding of patients Know about the advantages and disadvantages of different representations Aimed at which audience All Experience level Beginner
09:40	K8 Keynote: Evidence, Outreach and Governance Lessons from the American States Mark Gibson Director, Center for Evidence Based Policy, Oregon Health and Science University K8 Keynote: Evidence, Outreach and Governance Lessons from the American States Mark Gibson Director, Center for Evidence Based Policy, Oregon Health and Science University 26th Oct 2011 - 09:40 The Oregon Health Plan pioneered using clinical value and public participation to shape healthcare coverage. In two decades the science of research synthesis and the nature of public and industry advocacy have changed significantly. Multiple states now work together to obtain actionable evidence and to support its use in policy. Their experience includes improved care and cost savings. It also includes inefficiency from devolved decision making and difficulties finding the public interest in democratic processes. What single idea will make the biggest impact on healthcare today? "Health care democratization” has a utopian rhetorical ring, but in reality it may fall short of the ideal it evokes. Learning outcomes – after this session, participants will be able to: Identify how the science of research synthesis and the conduct of healthcare advocacy have changed over 20 years. Understand how some American states have evolved their policy making to address the challenges presented by changes in research and advocacy. Identify lessons learned from the US experience that could be useful to national health systems as they debate issues of governance devolution and democratization of health system decision making. Aimed at which audience Anyone concerned with health system performance, system governance, and stakeholder engagement Experience level Any level
10:10	K9 Keynote: Creating global guidance for vaccination and immunization Philippe Duclos Health Adviser Department of Immunization, Vaccines and Biologicals, WHO K9 Keynote: Creating global guidance for vaccination and immunization Philippe Duclos Health Adviser Department of Immunization, Vaccines and Biologicals, WHO 26th Oct 2011 - 10:10 The World Health Organization (WHO) has recently adjusted its policy making processes for vaccines and immunization. This includes an enlarged consultation process to generate evidence-based recommendations, ensuring the transparency of the decision making process, and improving communications. This presentation will describe the process and challenges of the development of immunization policy recommendations at the global level through the Strategic Advisory Group of Experts on immunization and the process leading to the publication of WHO position papers on vaccine use. A particular focus will be given to the challenges of using GRADE, updating recommendations and dealing with emergency situations and situations where there is a paucity of data. What single idea will make the biggest impact on healthcare today? Facilitate the exchange of information between immunization technical advisory committees and/or One ounce of prevention is better than one pound of cure.
10:40	Refreshments & poster viewing
11:10	D1 1. Evidence for value and efficiency Mike Kelly Director of the Centre of Public Health Excellence, NICE D1 Session: Evidence for value and efficiency Mike Kelly Director of the Centre of Public Health Excellence, NICE 26th Oct 2011 - 11:10 This paper explains the method for deriving value for money for public health interventions to prevent disease. It demonstrates he significant savings that can accrue from public health activity. What single idea will make the biggest impact on healthcare today? In the face of decline in available budgets for health care the spend on prevention must be preserved. Learning outcomes Apply principles of health economics to public health activity. Understand the methods used by NICE to develop measures of cost effectiveness. Think about the deployment of public health resources at local level. Aimed at what audience CEOs, local government, public health practitioners. Experience level Beginners/ experienced 2. Critically appraising evidence in knowledge translation - challenges for the future Juan Cabello Director, CASP España D1 Session: Critically appraising evidence in knowledge translation - challenges for the future Juan Cabello Director, CASP España 26th Oct 2011 - 11:10 Knowledge translation is essential to promote effective care and eliminate the ineffective. A huge effort has been made to build evidence, publish results and promote the transparency and quality of health research. Although critical appraisal is the next step in knowledge translation, it has received less attention. Current critical appraisal tools and the models of reading are discussed in this session, emphasizing the foreseeable changes induced by the new technologies and suggesting adaptation mechanisms. What single idea will make the biggest impact on healthcare today? Critical appraisal is the meeting point between the written evidence and its potential application. As written evidence evolves continuously, critical appraisal should develop adaptive strategies. Learning outcomes To identify the problems in reading the evidence and pre-appraised evidence. To know the strengths and weaknesses of the current critical appraisal tools. To predict problems related to the development of new information technologies in health. Aimed at which audience General audience: health workers, patients, citizens, or anyone interested in knowledge translation. 3. (New) Challenges of health technology assessment Stefan Lange Deputy Director, Institute for Quality and Efficiency in Health Care D1 Session: (New) Challenges of health technology assessment Stefan Lange Deputy Director, Institute for Quality and Efficiency in Health Care 26th Oct 2011 - 11:10 Decisions on the reimbursement of medical services are becoming more and more difficult for several reasons (e.g. increasing financial constraints). Therefore, the importance and requirements of health technology assessment are steadily increasing. Current challenges with regard to the assessment of medical interventions are: the validity of surrogates, the interpretability of indirect and mixed treatment comparisons, the appropriate evaluation of diagnostic procedures, and the criteria and quantification of effects as a basis for judging 'relevance'. What single idea will make the biggest impact on healthcare today? Decisions on reimbursement should be based on patient-relevant evidence that is as unbiased as possible Learning outcomes – after this session, participants will be able to: To understand the current challenges of health technology assessment Aimed at which audience Senior managers Experience level Experienced Chaired by Doug Altman Director, Centre for Statistics in Medicine, Oxford Chaired by Doug Altman Director, Centre for Statistics in Medicine, Oxford	D2 1. Using consumer information to inform guidelines Gill Gyte NCT and Cochrane Collaboration Consumer Network D2 Session: Using consumer information to inform guidelines Gill Gyte NCT and Cochrane Collaboration Consumer Network 26th Oct 2011 - 11:10 Introduction to consumer input into clinical guidelines Reporting on observations and suggestions arising from personal experiences of being a consumer representative on three clinical guideline development groups Discussing the need for a process for using consumer information to inform guidelines and looking at what such a process might involve What single idea will make the biggest impact on healthcare today? Ensure that guideline development groups include consumer information by providing a robust process which ensures good quality evidence based in information Learning outcomes – after this session, participants will be able to: Ensure that guideline development groups include consumer information by providing a robust process which ensures good quality evidence based in information Aimed at which audience All those involved in developing and using guidelines Experience level All levels 2. Involving the public in healthcare research debates – single or shared voice? Sally Crowe James Lind Alliance and Crowe Associates Ltd D2 Session: Involving the public in healthcare research debates – single or shared voice? Sally Crowe James Lind Alliance and Crowe Associates Ltd 26th Oct 2011 - 11:10 Describing James Lind Alliance and UK DUETs Collecting and publishing uncertainties in the effects of treatments – from multiple perspectives Describing a process for shared priorities in health care research The role of Priority Setting Partnerships of patients and clinicians, and their impact on research agendas Examples of methods used and outcomes recorded What happens when patients and clinicians do, and don’t agree on priorities The impact of shared priorities on funded clinical research What single idea will make the biggest impact on healthcare today? Democratizing clinical research – a process for producing transparently prioritized research questions that reflect patient/carer and clinical and research perspectives on ongoing uncertainties in healthcare. Aimed at which audience Anyone with a stake in clinical research, more relevance to clinicians and patients than managers 3. How does patient involvement make a difference to clinical research? Dr Kristina Staley D2 Session: How does patient involvement make a difference to clinical research? Dr Kristina Staley 26th Oct 2011 - 11:10 Defining patient involvement in research. The benefits of patient involvement: impact on research design impact on the ethical acceptability of research impact on recruitment impact on data quality The challenges of patient involvement: convincing researchers to involve patients building capacity amongst patients What single idea will make the biggest impact on healthcare today? Make high quality patient involvement a condition for funding clinical research. Learning outcomes – after this session, participants will be able to: Describe how patient involvement has had a positive impact on clinical research Reflect on the training and support needed by researchers and patients to work together on research Aimed at which audience Anyone with a stake in clinical research, more relevance to clinicians and patients than managers Experience level Not relevant Chaired by Sir Iain Chalmers James Lind Initiative, Oxford, UK Chaired by Sir Iain Chalmers James Lind Initiative, Oxford, UK	D3 INNOVATION ROOM A showcase and practical demonstration of new innovations and technology in evidence based healthcare 11:10 - BMJ Group Implementing EBM, Quality Improvement and the move to Practice Based Evidence Dr Andrew Jones, Clinical Engagement Specialist 11:35 - BMJ Informatica Systems Demonstration of Audit+ Speakers TBC 12:00 - Oxford Centre for Evidence Based Medicine and BMJ Evidence Centre Demonstrating the new EBM Application Speakers TBC D3 Session: INNOVATION ROOM 26th Oct 2011 - 11:10 A showcase and practical demonstration of new innovations and technology in evidence based healthcare 11:10 - BMJ Group Implementing EBM, Quality Improvement and the move to Practice Based Evidence Dr Andrew Jones, Clinical Engagement Specialist 11:35 - BMJ Informatica Systems Demonstration of Audit+ Speakers TBC 12:00 - Oxford Centre for Evidence Based Medicine and BMJ Evidence Centre Demonstrating the new EBM Application Speakers TBC Chaired by Matthew Thompson Deputy Director, Centre for Evidence-Based Medicine, University of Oxford Chaired by Matthew Thompson Deputy Director, Centre for Evidence-Based Medicine, University of Oxford
12:30	Lunch & poster viewing
13:30	E1 1. The payoffs and pitfalls of evidence-based global health policymaking Gavin Yamey Evidence to Policy initiative (E2Pi), Global Health Group, University of California San Francisco E1 Session: The payoffs and pitfalls of evidence-based global health policymaking Gavin Yamey Evidence to Policy initiative (E2Pi), Global Health Group, University of California San Francisco 26th Oct 2011 - 13:30 One of the reasons why progress has been slow in achieving the maternal and child health Millennium Development Goals is the wide gap between evidence and practical policymaking. Why does this gap persist? This session explores some of the key reasons, including the poor global flow of evidence, the sociopolitical influences on policymakers, and the complex and poorly understood apparatus of policy implementation. It will also propose ways to narrow the “know-do” gap in global health. What single idea will make the biggest impact on healthcare today? “Globally, joining the dots between different sectors—nutrition, education, water, sanitation, and climate—could make the biggest impact upon health and healthcare.” Learning outcomes - after the session, participants will be able to : To understand the factors that influence decision-making in global health To identify the key barriers to evidence-based policymaking in global health To identify some of the innovative ways in which these barriers can be overcome Aimed at which audience Anyone who works in global health, particularly public health professionals Experience level Beginners to masters level 2. Evidence for implementing change Professor Martin Marshall The Health Foundation E1 Session: Evidence for implementing change Professor Martin Marshall The Health Foundation 26th Oct 2011 - 13:30 Implementing best practice across the health service in a sustainable way remains one of the biggest challenges facing practitioners, policy makers and academics. The science of improvement is a relatively new science in the health sector and one that complements the long established basic and clinical sciences. By developing partnerships between academics and practitioners and drawing on a wide range of academic disciplines, it has the potential to address the challenge of implementing best practice. In this presentation, Professor Marshall will explore the characteristics, current contribution and future direction of the science of improvement. What single idea will make the biggest impact on healthcare today? Only a new approach to science will address the challenge of implementation. Learning outcomes – after this session, participants will be able to: Have an understanding of the nature of the science of improvement and its potential to improve patient outcomes. Aimed at which audience All! Experience Level All	E2 1. The impact of publishing research with open access Trish Groves BMJ Group E2 Session: The impact of publishing research with open access Trish Groves BMJ Group 26th Oct 2011 - 13:30 Arguments for open access (OA): public money spent only to fund research, not to access it audience not limited by ability to pay makes evidence more accessible more author-centric and user-centric shifts the concept of impact from citations --> downloads/usage Arguments against OA: quality vs quantity tradeoff? exacerbates publish or perish culture? end of the "reader"? threat to traditional journals? Practicalities: funders' OA mandates and why they matter how open peer review and OA can work together various models of OA What single idea will make the biggest impact on healthcare today? “Developing the right evidence and getting it to the right people at the right time and place will make the biggest impact on healthcare.” Learning outcomes – after this session, participants will be able to: to make more informed choices when deciding where to publish research to understand different concepts of the impact of research to understand more about peer review Aimed at which audience researchers people who use the results of research in their daily work or teaching Experience level All 2. What answering 10000+ clinical questions tells you about evidence Jon Brassey TRIP Database Ltd & Public Health Wales E2 Session: What answering 10000+ clinical questions tells you about evidence Jon Brassey TRIP Database Ltd & Public Health Wales 26th Oct 2011 - 13:30 The presentation will explore question answering using an evidence-based approach. It will explore search, the nature of evidence and why both need to dramatically improve to help clinicians practice in an evidence-based manner. It will draw on the experience of running the TRIP Database and various clinical Q&A services. What single idea will make the biggest impact on healthcare today? Removing the barriers to using evidence, by making it easily available and clinically focused, will ensure care is evidence based. Learning outcome – after this session, participants will be able to: Appreciate the need for clinically-focussed evidence Understand why search can be part of the problem as well as the answer Aimed at which audience General audience Experience Level Any Chaired by Ben Goldacre Award-winning writer, broadcaster, and medical doctor, writer of the weekly Guardian Bad Science column, and author of the book 'Bad Science' Chaired by Ben Goldacre Award-winning writer, broadcaster, and medical doctor, writer of the weekly Guardian Bad Science column, and author of the book 'Bad Science'	E3 RESEARCH SHOWCASE A selection of rapid-fire presentations highlighting the best of evidence based research in the scientific community E3 Session: RESEARCH SHOWCASE 26th Oct 2011 - 13:30 A selection of rapid-fire presentations highlighting the best of evidence based research in the scientific community Chaired by Doug Altman Director, Centre for Statistics in Medicine, Oxford Chaired by Doug Altman Director, Centre for Statistics in Medicine, Oxford
14:30	Refreshments & poster viewing
15:00	F1 1. Hayashi’s problem (what you read may not be what it seems) Tom Jefferson Editor Cochrane Acute Respiratory Infections Group F1 Session: Hayashi’s problem (what you read may not be what it seems) Tom Jefferson Editor Cochrane Acute Respiratory Infections Group 26th Oct 2011 - 15:00 Recent cases of exposure of sponsor bias overturning our understanding of important interventions (antipsychotics, riboxetine, vioxx, tamiflu) have shown that reliance on published material can be misleading and affected by reporting bias. However, only 10% of Cochrane reviews search for unpublished material. Using the story of the Cochrane review on Tamiflu as background, Tom will chart current efforts to develop methods for identifying and synthetising evidence from trials of important pharmaceuticals using regulatory-sourced material only. (Funding: HTA(UK) programme Project 10.80.01 – Update and amalgamation of two Cochrane Reviews: neuraminidase inhibitors for preventing and treating influenza in healthy adults and children) What single idea will make the biggest impact on healthcare today? Access to unbiased and unspun clinical trial data Learning outcomes Be aware of the limits of research synthesis and decision making based on published trial data Trust everything they read, after thorough verification Write to their MP to demand action from regulators to disclose all drug registration material in their keeping Aimed at which audience All healthcare workers Experience level Any 2. Left to their own devices (what evidence for medical devices?) Dr Deb Cohen Assistant Editor, BMJ F1 Session: Left to their own devices (what evidence for medical devices?) Dr Deb Cohen Assistant Editor, BMJ 26th Oct 2011 - 15:00 In both the EU and the US, medical device regulation has come in for scrutiny recently. The MHRA has said that the evidence base for most devices is poor. But how do devices get onto the market? And how are clinicians and other healthcare decision makers able to make judgments on what they use and purchase? This workshop will look at some of the challenges facing clinicians and those trying to assess the evidence. What single idea will make the biggest impact on healthcare today? Transparency in decision making alongside access to clinical trial data. Learning outcomes – after this session, participants will be able to: Learn about working collaboratively – researchers, journals and mainstream media Find out how to access data that might not be in medical journals – and find out about when it simply isn’t available Learn to question what you read Aimed at which audience All health workers Experience level Any Chaired by Fiona Godlee Editor in Chief, BMJ Chaired by Fiona Godlee Editor in Chief, BMJ	F2 1. Ageing of bruising – what’s the evidence? Prof Ian Wall Past President Faculty of Forensic and Legal Medicine F2 Session: Ageing of bruising – what’s the evidence? Prof Ian Wall Past President Faculty of Forensic and Legal Medicine 26th Oct 2011 - 15:00 There has been much speculation as to the age of a bruise, particularly from doctors who work in Emergency Departments. This presentation will look at the research evidence on ageing of bruising and consider the impact this has on the judicial process. What single idea will make the biggest impact on healthcare today? Be very cautious when trying to age bruises! Learning outcomes – after this session, participants will be able to: Understand the physiology of colour change in bruises. Understand the evidence base for ageing of bruises. Aimed at which audience Emergency Department, GPs, Forensic Physicians, Paediatricians Experience level All 2. Sexual Assault & Genital Injuries Dr Catherine White Chaired by Carl Heneghan Director, Centre for Evidence-Based Medicine, University of Oxford	F3 1. Using new technologies to deliver healthcare Lionel Tarassenko MA, DPhil, FREng, FIET Chair in Electrical Engineering at Oxford University 2. Social Media Annabel Bentley
16:05	Closing Reflections Fiona Godlee Editor in Chief, BMJ Carl Heneghan Director, Centre for Evidence-Based Medicine, University of Oxford
16:15	K10 Keynote: Sex, Sleep or Scramble? Dr Phil Hammond GP, writer, broadcaster and comedian. Private Eye’s medical correspondent and occasional panelist on Have I Got News For You. K10 Keynote: Sex, Sleep or Scramble? Dr Phil Hammond GP, writer, broadcaster and comedian. Private Eye’s medical correspondent and occasional panelist on Have I Got News For You. 26th Oct 2011 - 16:15 Phil reveals what goes through the mind of the doctor and will explore the evidence and answers to some of life’s quirkier medical queries.
17:00	Close